Issue: Volume XXIV No. 14 - October 9, 2017

Attention All Lab Professionals: It’s Time to Act!

AT THIS MOMENT, THE ENTIRE CLINICAL LABORATORY INDUSTRY STANDS on the precipice of the most financially disruptive development in the past three decades. On Jan. 1, the federal Centers for Medicare and Medicaid Services will implement deep cuts to the Medicare Part B Clinical Laboratory Fee Schedule. There is additional unwelcome news. CMS now says …

Attention All Lab Professionals: It’s Time to Act! Read More »

AMA, AHA Join Labs to Request Delay, Fix

CEO SUMMARY: In what may be a first for the clinical lab industry, the American Medical Association and the American Hospital Association joined with 20 other healthcare associations to ask CMS Administrator Seema Verma to address the problems with the CMS proposal involving Medicare Part B fees. Specifically, the associations asked Verma to delay implementing …

AMA, AHA Join Labs to Request Delay, Fix Read More »

For Top 20 Tests, CMS to Cut Payment by 28% in 2018-2020

ON SEPT. 22, MEDICARE OFFICIALS RELEASED THE DRAFT PRICES for the 2018 Clinical Laboratory Fee Schedule. The bad news for the lab industry is that the fee cuts are deeper than the federal Centers for Medicare and Medicaid Services had predicted earlier. The price cuts to clinical laboratory test fees will total $670 million in …

For Top 20 Tests, CMS to Cut Payment by 28% in 2018-2020 Read More »

Labs Serving Nursing Homes, Rural Areas to Suffer Most

CLINICAL LABORATORIES WITH A HIGH percentage of Medicare Part B lab test reimbursement are expected to suffer the most under the Part B Clinical Laboratory Fee Schedule (CLFS) cuts that the Centers for Medicare and Medicaid Services proposed Sept. 22. With the proposed rates scheduled to go into effect on Jan. 1, that leaves just …

Labs Serving Nursing Homes, Rural Areas to Suffer Most Read More »

Lab Associations Comment on CMS Actions, Lab Fees

FOR THE LAB INDUSTRY, THE FEE CUTS proposed in the 2018 Clinical Laboratory Fee Schedule would be even more aggressive than what the federal Centers for Medicare and Medicaid Services had earlier predicted for Medicare Part B. In the days following the Sept. 22 publication of the proposed fee schedule, major lab industry associations issued …

Lab Associations Comment on CMS Actions, Lab Fees Read More »

Here Are the Arguments When Commenting on 2018 CLFS Rates

ALL LABORATORY PROFESSIONALS AND pathologists are encouraged to submit comments to CMS before the Oct. 23, as well as send letters to their elected officials in Congress to urge both to delay and to fix the market price study and revise the proposed Clinical Laboratory Fee Schedule for 2018. Beneficiaries Will Lose Out Among the …

Here Are the Arguments When Commenting on 2018 CLFS Rates Read More »

October 9, 2017 Intelligence: Late Breaking Lab News

Sept. 22 was the day that an agreement to sell Miraca Life Sciences (MLS) of Irving, Texas, was announced. Miraca Holdings will sell the anatomic pathology lab company to Avista Capital Partners. As part of the transaction, a new holding company, called Symphony Buyer, will be formed and will own MLS. Miraca Holdings will be …

October 9, 2017 Intelligence: Late Breaking Lab News Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.